| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 4.734.149 $ | 91,49 | 313.016 | |||||||
| Xenon Pharmaceuticals Inc | XENON PHARMACEUTICALS INC | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 247.641 $ | 4,79 | 4.419 | |
| AXSOME THERAPEUTICS, INC. | AXSOME THERAPEUTICS INC | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 237.666 $ | 4,59 | 1.144 | |
| ARROWHEAD PHARMACEUTICALS, INC. | ARROWHEAD PHARMACEUTICALS INC | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 228.008 $ | 4,41 | 3.103 | |
| ALKERMES PUBLIC LIMITED COMPANY | ALKERMES PLC | EC | G01767105 | Long | Börsenkurs (Stufe 1) | 217.295 $ | 4,20 | 6.446 | |
| PTC THERAPEUTICS, INC. | PTC THERAPEUTICS INC | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 191.146 $ | 3,69 | 2.938 | |
| NEUROCRINE BIOSCIENCES, INC. | NEUROCRINE BIOSCIENCES INC | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 190.658 $ | 3,68 | 1.448 | |
| BIOGEN INC. | BIOGEN INC | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 190.037 $ | 3,67 | 1.004 | |
| Scholar Rock Holding Corp | SCHOLAR ROCK HOLDING CORP | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 189.936 $ | 3,67 | 4.075 | |
| Praxis Precision Medicines Inc | PRAXIS PRECISION MEDICINES INC | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 189.385 $ | 3,66 | 594 | |
| ACADIA PHARMACEUTICALS INC. | ACADIA PHARMACEUTICALS INC | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 186.964 $ | 3,61 | 8.328 | |
| Dianthus Therapeutics Inc | DIANTHUS THERAPEUTICS INC | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 175.424 $ | 3,39 | 1.998 | |
| CATALYST PHARMACEUTICALS, INC. | CATALYST PHARMACEUTICALS INC | EC | 14888U101 | Long | Börsenkurs (Stufe 1) | 170.130 $ | 3,29 | 6.048 | |
| Denali Therapeutics Inc | DENALI THERAPEUTICS INC | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 146.016 $ | 2,82 | 7.800 | |
| SUPERNUS PHARMACEUTICALS, INC. | SUPERNUS PHARMACEUTICALS INC | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 144.000 $ | 2,78 | 3.000 | |
| Edgewise Therapeutics Inc | EDGEWISE THERAPEUTICS INC | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 131.023 $ | 2,53 | 4.232 | |
| Dyne Therapeutics, Inc | DYNE THERAPEUTICS INC | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 122.253 $ | 2,36 | 6.966 | |
| AxoGen, Inc. | AXOGEN INC | EC | 05463X106 | Long | Börsenkurs (Stufe 1) | 120.960 $ | 2,34 | 2.800 | |
| SAREPTA THERAPEUTICS, INC. | SAREPTA THERAPEUTICS INC | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 114.422 $ | 2,21 | 5.480 | |
| SK Biopharmaceuticals Co Ltd | SK BIOPHARMACEUTICALS CO LTD | EC | Y806MN108 | Long | Modellwert (Stufe 2) | 105.634 $ | 2,04 | 1.547 | |
| H. LUNDBECK A/S | H LUNDBECK A S | EC | DK0061804770 | Long | Modellwert (Stufe 2) | 99.239 $ | 1,92 | 14.762 | |
| Capricor Therapeutics Inc | CAPRICOR THERAPEUTICS INC | EC | 14070B309 | Long | Börsenkurs (Stufe 1) | 90.431 $ | 1,75 | 2.693 | |
| Taysha Gene Therapies Inc | TAYSHA GENE THERAPIES INC | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 79.038 $ | 1,53 | 12.369 | |
| BioArctic AB | BIOARCTIC AB | EC | SE0010323311 | Long | Börsenkurs (Stufe 1) | 71.053 $ | 1,37 | 2.026 | |
| Biohaven Ltd | BIOHAVEN LTD | EC | G1110E107 | Long | Börsenkurs (Stufe 1) | 67.283 $ | 1,30 | 7.016 | |
| Neuren Pharmaceuticals Ltd | NEUREN PHARMACEUTICALS LTD | EC | NZNEUE0001S8 | Long | Modellwert (Stufe 2) | 54.702 $ | 1,06 | 6.016 | |
| Rapport Therapeutics Inc | RAPPORT THERAPEUTICS INC | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 53.339 $ | 1,03 | 1.610 | |
| Dynavox Group AB | DYNAVOX GROUP AB | EC | SE0017105620 | Long | Modellwert (Stufe 2) | 48.446 $ | 0,94 | 5.451 | |
| Bright Minds Biosciences Inc | BRIGHT MINDS BIOSCIENCES INC | EC | 10919W405 | Long | Börsenkurs (Stufe 1) | 47.405 $ | 0,92 | 539 | |
| Idorsia Ltd | IDORSIA LTD | EC | CH0363463438 | Long | Börsenkurs (Stufe 1) | 45.098 $ | 0,87 | 9.565 | |
| Annexon Inc | ANNEXON INC | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 41.372 $ | 0,80 | 7.048 | |
| Alto Neuroscience Inc | ALTO NEUROSCIENCE INC | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 40.312 $ | 0,78 | 1.571 | |
| SanBio Company Limited | SANBIO CO LTD | EC | JP3336750009 | Long | Modellwert (Stufe 2) | 38.842 $ | 0,75 | 3.200 | |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | INTEGRA LIFESCIENCES HOLDINGS CORP | EC | 457985208 | Long | Börsenkurs (Stufe 1) | 38.735 $ | 0,75 | 3.675 | |
| Medincell SA | MEDINCELL SA | EC | FR0004065605 | Long | Börsenkurs (Stufe 1) | 33.455 $ | 0,65 | 1.155 | |
| LB Pharmaceuticals Inc | LB PHARMACEUTICALS INC | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 32.852 $ | 0,63 | 1.036 | |
| Ceribell Inc | CERIBELL INC | EC | 15678C102 | Long | Börsenkurs (Stufe 1) | 26.954 $ | 0,52 | 1.337 | |
| Prothena Corporation PLC | PROTHENA CORP PLC | EC | G72800108 | Long | Börsenkurs (Stufe 1) | 26.456 $ | 0,51 | 2.392 | |
| Zylox-Tonbridge Medical Technology Co Ltd | ZYLOX TONBRIDGE MEDICAL TECHNOLOGY CO LTD | EC | CNE100004JD2 | Long | Börsenkurs (Stufe 1) | 26.359 $ | 0,51 | 9.000 | |
| Oncolys Biopharma Inc | ONCOLYS BIOPHARMA INC | EC | J61461109 | Long | Modellwert (Stufe 2) | 25.402 $ | 0,49 | 1.400 | |
| Relmada Therapeutics Inc | RELMADA THERAPEUTICS INC | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 25.072 $ | 0,48 | 3.334 | |
| Solid Biosciences Inc | SOLID BIOSCIENCES INC | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 23.973 $ | 0,46 | 3.302 | |
| MicroPort NeuroScientific Corp | MICROPORT NEUROSCIENTIFIC CORP | EC | KYG6083E1098 | Long | Modellwert (Stufe 2) | 23.965 $ | 0,46 | 18.000 | |
| Design Therapeutics Inc | DESIGN THERAPEUTICS INC | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 23.718 $ | 0,46 | 1.744 | |
| Neuropace Inc | NEUROPACE INC | EC | 641288105 | Long | Börsenkurs (Stufe 1) | 23.570 $ | 0,46 | 1.398 | |
| Regenxbio Inc | REGENXBIO INC | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 22.712 $ | 0,44 | 2.532 | |
| Benitec Biopharma Inc | BENITEC BIOPHARMA INC | EC | 08205P209 | Long | Börsenkurs (Stufe 1) | 21.666 $ | 0,42 | 1.798 | |
| MapLight Therapeutics Inc | MAPLIGHT THERAPEUTICS INC | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 21.576 $ | 0,42 | 677 | |
| VANDA PHARMACEUTICALS INC. | VANDA PHARMACEUTICALS INC | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 21.272 $ | 0,41 | 2.996 | |
| PEIJIA MEDICAL LIMITED | PEIJIA MEDICAL LTD | EC | G6981F109 | Long | Modellwert (Stufe 2) | 20.679 $ | 0,40 | 26.000 | |
| Newron Pharmaceuticals SpA | NEWRON PHARMACEUTICALS SPA | EC | T6916C102 | Long | Börsenkurs (Stufe 1) | 18.137 $ | 0,35 | 991 | |
| NEUROGENE INC. | NEUROGENE INC | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 17.689 $ | 0,34 | 678 | |
| OVID THERAPEUTICS INC. | OVID THERAPEUTICS INC | EC | 690469101 | Long | Börsenkurs (Stufe 1) | 17.628 $ | 0,34 | 6.364 | |
| Anavex Life Sciences Corp | ANAVEX LIFE SCIENCES CORP | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 16.510 $ | 0,32 | 4.943 | |
| Entrada Therapeutics Inc | ENTRADA THERAPEUTICS INC | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 15.903 $ | 0,31 | 1.178 | |
| Clearpoint Neuro Inc | CLEARPOINT NEURO INC | EC | 18507C103 | Long | Börsenkurs (Stufe 1) | 15.853 $ | 0,31 | 1.418 | |
| Santhera Pharmaceuticals Holding AG | SANTHERA PHARMACEUTICALS HOLDING AG | EC | H7155R142 | Long | Modellwert (Stufe 2) | 14.291 $ | 0,28 | 656 | |
| AC Immune SA | AC IMMUNE SA | EC | H00263105 | Long | Börsenkurs (Stufe 1) | 10.151 $ | 0,20 | 3.350 | |
| Alector Inc | ALECTOR INC | EC | 014442107 | Long | Börsenkurs (Stufe 1) | 9.736 $ | 0,19 | 4.108 | |
| Inhibikase Therapeutics Inc | INHIBIKASE THERAPEUTICS INC | EC | 45719W205 | Long | Börsenkurs (Stufe 1) | 9.601 $ | 0,19 | 5.080 | |
| Voyager Therapeutics Inc | VOYAGER THERAPEUTICS INC | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 9.377 $ | 0,18 | 2.514 | |
| Larimar Therapeutics Inc | LARIMAR THERAPEUTICS INC | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 9.261 $ | 0,18 | 2.281 | |
| TONIX PHARMACEUTICALS HOLDING CORP. | TONIX PHARMACEUTICALS HOLDING CORP | EC | 890260839 | Long | Börsenkurs (Stufe 1) | 8.896 $ | 0,17 | 688 | |
| Myung In Pharm Co Ltd | MYUNG IN PHARMA CO LTD | EC | Y6S5DX102 | Long | Modellwert (Stufe 2) | 8.041 $ | 0,16 | 211 | |
| Neumora Therapeutics Inc | NEUMORA THERAPEUTICS INC | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 7.558 $ | 0,15 | 3.060 | |
| Acumen Pharmaceuticals Inc | ACUMEN PHARMACEUTICALS INC | EC | 00509G209 | Long | Börsenkurs (Stufe 1) | 6.106 $ | 0,12 | 2.555 | |
| PepGen Inc | PEPGEN INC | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 5.504 $ | 0,11 | 3.356 | |
| Cognition Therapeutics Inc | COGNITION THERAPEUTICS INC | EC | 19243B102 | Long | Börsenkurs (Stufe 1) | 5.472 $ | 0,11 | 4.343 | |
| BrainAurora Medical Technology Ltd | BRAINAURORA MEDICAL TECHNOLOGY LTD | EC | G1300R108 | Long | Börsenkurs (Stufe 1) | 4.839 $ | 0,09 | 10.000 | |
| Gain Therapeutics Inc | GAIN THERAPEUTICS INC | EC | 36269B105 | Long | Börsenkurs (Stufe 1) | 3.871 $ | 0,07 | 2.048 | |
| Filana Therapeutics, Inc | FILANA THERAPEUTICS INC | EC | 14817C107 | Long | Börsenkurs (Stufe 1) | 3.563 $ | 0,07 | 2.457 | |
| SANGAMO THERAPEUTICS, INC. | SANGAMO THERAPEUTICS INC | EC | 800677106 | Long | Börsenkurs (Stufe 1) | 2.590 $ | 0,05 | 21.725 | |
| 4.734.149 $ | 91,49 | 313.016 |